Deutsche Bank raises its price target to $100 from $94 on LabCorp of America LH on mixed results from Q4.
Deutsche Bank says, "EPS beat and margins demonstrated progress w/M&A integration, yet rev was slightly below expectations. On a sql w/Q3, mgmt characterized MCO pricing as better and vols as stable. The deceleration in rev growth during 2H has colored mgmt's 2012 outlook of 2-3.5% to be below the 4-6% "foundation model". We believe there are upside risks to rev growth as demand picks up, but even w/+3.5% rev growth, our EPS growth est. points to low-teens (repo and M&A margin gains)."
LH closed at $90.03 on Friday.
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in